(Q40758034)

23 September 2017

1 reference

title

The fate of exogenous surfactant in neonates with respiratory distress syndrome (English)

1 reference

23 September 2017

M Hallman

1

1 reference

23 September 2017

T A Merritt

series ordinal

2

1 reference

23 September 2017

K Bry

series ordinal

3

1 reference

23 September 2017

language of work or name

1 reference

1 March 1994

1 reference

Clinical Pharmacokinetics

23 September 2017

1 reference

23 September 2017

26

1 reference

23 September 2017

3

1 reference

23 September 2017

215-232

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199426030-00005

23 September 2017

0 references

cites work

Aerosolized surfactant treatment of preterm lambs

1 reference

12 December 2020

Studies on lung surfactant replacement in respiratory distress syndrome. Rapid film formation from binary mixed liposomes

1 reference

12 December 2020

Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1

1 reference

12 December 2020

A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network

1 reference

12 December 2020

Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome

1 reference

12 December 2020

Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation

1 reference

12 December 2020

Lung surfactant in respiratory distress syndrome

1 reference

12 December 2020

Metabolism of endogenous surfactant and exogenous surfactants for replacement therapy

1 reference

12 December 2020

Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant

1 reference

12 December 2020

Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.

1 reference

12 December 2020

Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA

1 reference

12 December 2020

A biophysical mechanism by which plasma proteins inhibit lung surfactant activity

1 reference

12 December 2020

Dry artificial lung surfactant and its effect on very premature babies

1 reference

12 December 2020

Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure

1 reference

12 December 2020

Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups

1 reference

12 December 2020

Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study

1 reference

12 December 2020

Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A

1 reference

12 December 2020

Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial

1 reference

12 December 2020

Turnover of exogenous artificial surfactant

1 reference

12 December 2020

Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein

1 reference

12 December 2020

Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B.

1 reference

12 December 2020

Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits.

1 reference

12 December 2020

Surfactant Protein A, Phosphatidylcholine, and Surfactant Inhibitors in Epithelial Lining Fluid: Correlation with Surface Activity, Severity of Respiratory Distress Syndrome, and Outcome in Small Premature Infants

1 reference

12 December 2020

A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation

1 reference

12 December 2020

A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome

1 reference

12 December 2020

Immunologic consequences of exogenous surfactant administration

1 reference

12 December 2020

The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants

1 reference

12 December 2020

Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome

1 reference

12 December 2020

Synthesis and assembly of lung surfactant

1 reference

12 December 2020

Immunogenicity and immunomodulatory activity of bovine surfactant (SF-RI 1)

1 reference

12 December 2020

Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis

1 reference

12 December 2020

Respiratory distress syndrome in very low birth weigh infants with occasionally normal surfactant phospholipids

1 reference

12 December 2020

Pulmonary surfactant and its apoproteins

1 reference

12 December 2020

Surfactant-associated Proteins in Tracheal Aspirates of Infants with Respiratory Distress Syndrome after Surfactant Therapy

1 reference

12 December 2020

Tracheal deposition of surfactant before the first breath

1 reference

12 December 2020

Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage

1 reference

12 December 2020

Requirements for extracellular metabolism of pulmonary surfactant: tentative identification of serine protease

1 reference

12 December 2020

Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial

1 reference

12 December 2020

Surfactant for the treatment of respiratory distress syndrome

1 reference

12 December 2020

Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages

1 reference

12 December 2020

Clearance of treatment doses of surfactant. Effect of lipid extraction and aggregate sizes

1 reference

12 December 2020

Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury

1 reference

12 December 2020

Biochemical Development of Surface Activity in Mammalian Lung. IV. Pulmonary Lecithin Synthesis in the Human Fetus and Newborn and Etiology of the Respiratory Distress Syndrome

1 reference

12 December 2020

Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome

1 reference

12 December 2020

Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial

1 reference

12 December 2020

Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage

1 reference

12 December 2020

Surfactant phospholipids: synthesis and storage

1 reference

12 December 2020

Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome

1 reference

12 December 2020

Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits

1 reference

12 December 2020

Characterization of bovine surfactant for infants with respiratory distress syndrome

1 reference

12 December 2020

Surfactant replacement. A new era with many challenges for neonatal medicine

1 reference

12 December 2020

Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf

1 reference

12 December 2020

Surfactant metabolism in surfactant-treated preterm ventilated lambs

1 reference

12 December 2020

Metabolism and turnover of lung surfactant

1 reference

12 December 2020

Artificial surfactant therapy in hyaline-membrane disease

1 reference

12 December 2020

Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs.

1 reference

12 December 2020

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

1 reference

12 December 2020

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

1 reference

12 December 2020

Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial

1 reference

12 December 2020

Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment

1 reference

12 December 2020

Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant

1 reference

12 December 2020

Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation

1 reference

12 December 2020

Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency

1 reference

12 December 2020

Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation

1 reference

12 December 2020

Lung phospholipids of human fetuses and infants with and without hyaline membrane disease

1 reference

12 December 2020

Endobronchial surface active phospholipids in various pulmonary diseases.

1 reference

12 December 2020

Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant

1 reference

12 December 2020

Surfactant Substitution in Ventilated Very Low Birth Weight Infants: Factors Related to Response Types

1 reference

12 December 2020

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

12 December 2020

Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome

1 reference

12 December 2020

10.2165/00003088-199426030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference